26 Apr 2017 | 4:41 PM
Research Report
Daily

Equity Research Report: Religare Morning Digest

Nifty has almost tested 7600 support level on Friday and closed marginally above the same. Now, we expect volatility to cool-down a bit and base formation is likely around the current level.
07 Sep 2015 | 07:00 AM

    Highlights for Today
 
Market Outlook for the day -Nifty has almost tested 7600 support level on Friday and closed marginally above the same. Now, we expect volatility to cool-down a bit and base formation is likely around the current level.
Key Indices – Levels to watch out for the day
INDEX (Spot) RESISTANCE 2 RESISTANCE 1 LTP SUPPORT 1 SUPPORT 2
SENSEX 25600 25420 25201.90 25000 24845
NIFTY 7800 7730 7655.05 7600 7550
BANKNIFTY 16600 16325 16129.10 15975 15750
CNX-IT 11710 11555 11413.60 11310 11200
News -
  • Aurobindo Pharma Ltd has received the final approval from the US Food & Drug Administration (USFDA) to manufacture and market Telmisartan tablets.
  • Cipla has entered into agreements to buy two United States based companies InvaGen Pharmaceuticals Inc and Exelan Pharmaceuticals Inc, for a consideration $ 550 million (estimated Rs. 3,630 crore). The combined revenue of these companies is $200 million up to December 2014.
  • ONGC’s overseas arm ONGC Videsh Ltd has agreed to buy a 15 per cent stake in Russian oil major Rosneft’s subsidiary Vankorneft.
 
    Trading/ Investment Ideas
Technical Calls
Company
Name
Recommendation CMP Initiation
Range
Stop
loss
Target Time
Frame
IOC BUY 408.85 404 - 405 392 435 3-5 Days
RECLTD SELL FUT 235.1 240 - 242 248 228 3-5 Days
 
Derivatives Call
Company
Name
Recommendation CMP Initiation
Range
Stop
loss
Target Time
Frame
COALINDIA BUY 350 CE 11.25 10.50 6.50 19 3-5 Days
 
Master Pick (1-2 Months)
Company
Name
Recommendation CMP Initiation
Range
Stop
loss
Target
SRTRANSFIN BUY 857.05 845-858 785 1020
To read complete report, please click here
 
Fundamental Picks for delivery ( 9 Months - 1 Year)
Company
Name
Recommendation CMP Initiation
Range
Target
KOTAKBANK BUY 606.30 705.10 900
Note – For our running recommendations and past performance, please click here
Research Disclaimer